Stride Soles Disrupts $6.7 Billion Orthotics Market with Direct-to-Consumer, Tech-Enabled Custom Insoles

As demand for orthopedic insoles accelerates, Stride Soles eliminates barriers to clinical-grade orthotics with a digital-first, sustainable model

NEW YORK, July 22, 2025 /PRNewswire/ -- With orthopedic insole demand projected to more than double from $3.2 billion in 2025 to $6.7 billion by 2035, Stride Soles is redefining access to clinical-grade custom orthotics. By eliminating traditional barriers of cost, access, and production time, Stride delivers precision-fit orthotics through a direct-to-consumer platform.